BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3923491)

  • 1. Measurement by electrical impedance aggregometry of porcine platelets response to selected physiological agonists.
    Gewirtz H; Steiner M; Sasken H; Most AS
    Proc Soc Exp Biol Med; 1985 Jul; 179(3):324-30. PubMed ID: 3923491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole blood platelet aggregation in humans and animals: a comparative study.
    Soloviev MV; Okazaki Y; Harasaki H
    J Surg Res; 1999 Apr; 82(2):180-7. PubMed ID: 10090827
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
    Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
    J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
    Romstedt K; Huzoor-Akbar
    Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of heparin on platelet aggregation in vitro].
    RĂ³ka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of thromboxane A2.
    Ambler J; Birch J; Maguire ED; Wallis RB
    Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of the aggregation responses of camel platelets.
    Al Ghumlas AK; Gader AG
    Vet Clin Pathol; 2013 Sep; 42(3):307-13. PubMed ID: 23919654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect on human platelets of catecholamines at levels achieved in the circulation.
    Ardlie NG; McGuiness JA; Garrett JJ
    Atherosclerosis; 1985 Dec; 58(1-3):251-9. PubMed ID: 3004519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin and platelet function.
    Ohlstein EH; Storer B; Nambi P; Given M; Lippton H
    Thromb Res; 1990 Mar; 57(6):967-74. PubMed ID: 2116686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low molecular weight heparin as an anticoagulant for in vitro platelet function studies.
    van Wyk V; Heyns AD
    Thromb Res; 1990 Feb; 57(4):601-9. PubMed ID: 2158153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of streptozocin-induced diabetes on platelet aggregation as determined by impedance aggregometry and platelet secretion: a possible role for nitric oxide.
    Judge S; Mammen E; Dunbar JC
    J Assoc Acad Minor Phys; 1995; 6(3):100-4. PubMed ID: 7663098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis.
    Di Minno G; Martinez J; McKean ML; De La Rosa J; Burke JF; Murphy S
    Am J Med; 1985 Nov; 79(5):552-9. PubMed ID: 3933340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of canine platelet function II. Catecholamines.
    Meyers KM; Huston LY; Clemmons RM
    Am J Physiol; 1983 Jul; 245(1):R100-9. PubMed ID: 6869571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of the synergistic actions of platelet agonists.
    Huang EM; Detwiler TC
    Blood; 1981 Apr; 57(4):685-91. PubMed ID: 7470619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ethanol on pathways of platelet aggregation in vitro.
    Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
    Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation with epinephrine of macaque platelet aggregation by other agonists: implications for studies on human atherosclerosis.
    Beatty CH; Howard CF; Caruso V
    Thromb Res; 1986 Feb; 41(4):447-58. PubMed ID: 3083525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
    Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
    Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of granulocyte elastase-like proteinase (ELP) on platelet functions.
    Taki M; Miura T; Inagaki M; Tomita Y; Saito N; Okada Y; Tsuda Y; Meguro T; Yamada K
    Thromb Res; 1986 Mar; 41(6):837-46. PubMed ID: 3010492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of prostacyclin (epoprostenol) on the aggregation of human platelets in whole blood in vitro.
    Saniabadi AR; Lowe GD; Belch JJ; Barbenel JC; Forbes CD
    Haemostasis; 1984; 14(6):487-94. PubMed ID: 6442909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.